Dapagliflozin in Heart Failure with Preserved Ejection Fraction
Copyright policy )Dapagliflozin in Heart Failure with Preserved Ejection Fraction
To the Editor: Solomon et al. (Sept. 22 issue)(1) report on the Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved Ejection Fraction Heart Failure (DELIVER) trial, which showed reduced risks of heart failure-related outcomes (hospitalization for heart failure or an urgent visit for heart failure) among patients with a mildly reduced or preserved left ventricular ejection fraction who received dapagliflozin. These findings are likely to be included in guidelines and shape clinical practice shortly. One interesting aspect of the trial was confirmation that dapagliflozin was effective in patients with a left ventricular ejection fraction of 60% or more . . .
- Brigham and Women's Faulkner Hospital United States
- University of Glasgow United Kingdom
- Sahlgrenska University Hospital Sweden
- Ospedale Niguarda Ca' Granda Italy
- Agostino Gemelli University Polyclinic Italy
Congestive heart failure, Heart Failure, Humans, Stroke Volume, Benzhydryl Compounds, Ventricular Function, Left
Congestive heart failure, Heart Failure, Humans, Stroke Volume, Benzhydryl Compounds, Ventricular Function, Left
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!